Brainsway Ltd. (BWAY) shareholders
Close on Nov 16, 2026Market cap $367.77MP/E 52.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jonathan Shulkin Joint filing with Antonio Gracias (14.90%), Valor Siren Ventures II L.P. (13.70%) and 8 more | 5,851,444 | 15.00% | 13D (active) amendment | Oct 6, 2025 |
| Harel Insurance Investments & Financial Services Ltd. | 3,265,397 | 8.30% | 13G (passive) amendment | Jun 30, 2026 |
| Meitav Investment House Ltd Joint filing with Meitav Provident Funds & Pension Ltd (5.16%) | 2,532,352 | 6.31% | 13G (passive) amendment | Jun 1, 2026 |
| Harel Insurance Investments & Financial Services Ltd | 1,981,714 | 5.20% | 13G (passive) | Feb 16, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BWAY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Valor Management LLC | 5,314,950 | – | $82.43M | – | 0.10% |
| Masters Capital Management LLC | 1,500,000 | – | $23.27M | −150,000 | 0.60% |
| Acadian Asset Management LLC | 807,931 | – | $12.51M | −10,341 | 0.01% |
| Essex Investment Management Co LLC | 592,606 | – | $9.19M | −25,947 | 1.20% |
| Renaissance Technologies LLC | 475,920 | – | $7.38M | −42,500 | 0.01% |
| Cresset Asset Management, LLC | 314,924 | – | $4.88M | – | 0.02% |
| Y.D. More Investments Ltd | 237,433 | – | $3.68M | −34,571 | 0.11% |
| Legato Capital Management LLC | 197,635 | – | $3.07M | +5,485 | 0.25% |
| Morgan Stanley | 188,968 | – | $2.93M | +84,574 | 0.00% |
| Eagle Global Advisors LLC | 182,606 | – | $2.83M | +10,000 | 0.09% |
| ARK Investment Management LLC | 142,500 | – | $2.21M | −51,186 | 0.01% |
| Sei Investments Co | 119,717 | – | $1.86M | −106,661 | 0.00% |
| UBS Group AG | 101,077 | – | $1.57M | +18,935 | 0.00% |
| Sigma Planning Corp | 100,435 | – | $1.56M | +30,072 | 0.04% |
| Two Sigma Investments, LP | 99,545 | – | $1.54M | −28,642 | 0.00% |
| Royce & Associates LP | 97,033 | – | $1.50M | – | 0.01% |
| JPMorgan Chase & Co | 96,807 | – | $1.47M | +49,777 | 0.00% |
| Goldman Sachs Group Inc | 92,091 | – | $1.43M | −15,621 | 0.00% |
| Toroso Investments, LLC | 89,248 | – | $1.38M | +74,193 | 0.00% |
| Huntleigh Advisors, Inc. | 87,306 | – | $1.35M | +5,787 | 0.19% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 11M | 8 / 15 | 19 / 8 | 0M | 1M |
| Q1 2026 | 56 | 12M | 21 / 16 | 13 / 8 | 1M | 1M |
| Q4 2025 | 43 | 12M | 7 / 16 | 13 / 8 | 2M | 1M |
| Q3 2025 | 44 | 11M | 10 / 17 | 8 / 7 | 1M | 1M |
| Q2 2025 | 42 | 12M | 5 / 11 | 19 / 5 | 0M | 1M |
| Q1 2025 | 42 | 12M | 9 / 11 | 12 / 6 | 1M | 0M |
| Q4 2024 | 39 | 12M | 11 / 12 | 14 / 4 | 6M | 1M |
| Q3 2024 | 32 | 7M | 7 / 14 | 5 / 2 | 1M | 1M |
| Q2 2024 | 27 | 7M | 5 / 5 | 12 / 7 | 1M | 1M |
| Q1 2024 | 29 | 7M | 8 / 10 | 7 / 6 | 1M | 2M |
| Q4 2023 | 27 | 9M | 12 / 6 | 7 / 0 | 2M | 3M |
| Q3 2023 | 15 | 10M | 2 / 7 | 2 / 3 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
12 funds held BWAY in Q2 2026, 22% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BWAY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Timothy Plan Israel Common Values Fund | 182,606 | – | $2.83M | 1.38% | Jun 30, 2026 |
| ARK Israel Innovative Technology ETF | 146,850 | – | $2.24M | 1.63% | Jul 31, 2026 |
| 1290 Essex Small Cap Growth Fund | 138,592 | – | $2.11M | 1.82% | Jul 31, 2026 |
| Royce Smaller-Companies Growth Fund | 97,000 | – | $1.50M | 0.63% | Jun 30, 2026 |
| Amplify BlueStar Israel Technology ETF | 74,453 | – | $1.15M | 0.96% | Jun 30, 2026 |
| Steward Values Enhanced International Fund | 25,351 | – | $386.10K | 0.11% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 19,005 | – | $301.99K | 0.03% | May 31, 2026 |
| Even Herd Long Short ETF | 14,795 | – | $229.47K | 0.38% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 13,705 | – | $217.77K | 0.00% | May 31, 2026 |
| Voya Multi-Manager International Small Cap Fund | 9,834 | – | $149.77K | 0.03% | Jul 31, 2026 |
| Defiance Autism Impact ETF | 2,250 | – | $34.90K | 2.58% | Jun 30, 2026 |
| iShares Neuroscience and Healthcare ETF | 1,724 | – | $26.26K | 0.48% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 800 | – | $12.41K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Gilad Moiseyev | Chief Technology Officer | 53,098 | Jun 22, 2026 |
| Yiftach Roth | Chief Scientist | 1,074,305 | Jun 3, 2026 |
| Colleen Hanlon | VP of Medical Affairs | 53,881 | Mar 18, 2026 |
| Hadar Levy | Chief Executive Officer | 123,050 | Mar 18, 2026 |
| Ido Marom | Chief Financial Officer | 51,250 | Mar 18, 2026 |
| Naomi Rozenfeld | Chief Marketing Officer | 25,000 | Mar 18, 2026 |
| Rayten Michal Ety Mitrany | Director | 12,500 | May 26, 2026 |
| Jonathan K. Shulkin | Director | 5,851,444 | Mar 18, 2026 |
| David Zacut | Director | 1,791,468 | Mar 18, 2026 |
| Karen Sarid | Director | 12,500 | Mar 18, 2026 |
| Amiram Boehm | Director | 18,750 | Mar 18, 2026 |
| Abraham Zangen | Director | 905,963 | Mar 18, 2026 |
| Avner Lushi | Director | 6,250 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gilad Moiseyev Chief Technology Officer | Jun 15, 2026 | Sale | −5,000 | – | – | 53,098 |
| Yiftach Roth Chief Scientist | Jun 2, 2026 | Sale | −1,000 | – | – | 1,074,305 |
| Yiftach Roth Chief Scientist | Jun 2, 2026 | Sale | −2,000 | – | – | 1,072,305 |
| Yiftach Roth Chief Scientist | Jun 1, 2026 | Sale | −2,000 | – | – | 1,077,305 |
| Yiftach Roth Chief Scientist | Jun 1, 2026 | Sale | −2,000 | – | – | 1,075,305 |
| Rayten Michal Ety Mitrany Director | May 26, 2026 | Sale | −7,980 | – | – | 12,500 |
| Gilad Moiseyev Chief Technology Officer | May 25, 2026 | Option exercise | +7,500 | – | – | 60,000 |
| Gilad Moiseyev Chief Technology Officer | May 25, 2026 | Tax withholding | −1,902 | – | – | 58,098 |
| Rayten Michal Ety Mitrany Director | May 25, 2026 | Sale | −10,000 | – | – | 20,480 |
| Rayten Michal Ety Mitrany Director | May 20, 2026 | Option exercise | +17,500 | – | – | 36,560 |
| Rayten Michal Ety Mitrany Director | May 20, 2026 | Tax withholding | −6,080 | – | – | 30,480 |
| Rayten Michal Ety Mitrany Director | May 19, 2026 | Option exercise | +10,000 | – | – | 22,500 |
| Rayten Michal Ety Mitrany Director | May 19, 2026 | Tax withholding | −3,440 | – | – | 19,060 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Brainsway's stock actually held short. Settlement fails (shares not delivered on time) peaked at 386 shares on Sep 2, 2026 over the last 90 days.
See a number that looks wrong?